DE69232417T2 - Michellamine zur verwendung als antivirale wirkstoffe, zusammensetzung und behandlungsverfahren - Google Patents

Michellamine zur verwendung als antivirale wirkstoffe, zusammensetzung und behandlungsverfahren

Info

Publication number
DE69232417T2
DE69232417T2 DE69232417T DE69232417T DE69232417T2 DE 69232417 T2 DE69232417 T2 DE 69232417T2 DE 69232417 T DE69232417 T DE 69232417T DE 69232417 T DE69232417 T DE 69232417T DE 69232417 T2 DE69232417 T2 DE 69232417T2
Authority
DE
Germany
Prior art keywords
antiviral compounds
michellamine
composition
antiviral
active substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69232417T
Other languages
English (en)
Other versions
DE69232417D1 (de
Inventor
Michael R Boyd
Ii Cardellina
Kirk P Manfredi
John W Blunt
Lewis K Pannell
James B Mcmahon
Robert J Gulakowski
Gordon M Cragg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of DE69232417D1 publication Critical patent/DE69232417D1/de
Application granted granted Critical
Publication of DE69232417T2 publication Critical patent/DE69232417T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
DE69232417T 1991-04-12 1992-04-10 Michellamine zur verwendung als antivirale wirkstoffe, zusammensetzung und behandlungsverfahren Expired - Fee Related DE69232417T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68419791A 1991-04-12 1991-04-12
PCT/US1992/002805 WO1992018125A1 (en) 1991-04-12 1992-04-10 Michellamines useful as antiviral agents, composition and method of treatment

Publications (2)

Publication Number Publication Date
DE69232417D1 DE69232417D1 (de) 2002-03-21
DE69232417T2 true DE69232417T2 (de) 2002-10-24

Family

ID=24747059

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69232417T Expired - Fee Related DE69232417T2 (de) 1991-04-12 1992-04-10 Michellamine zur verwendung als antivirale wirkstoffe, zusammensetzung und behandlungsverfahren

Country Status (7)

Country Link
US (2) US5455251A (de)
EP (1) EP0594795B1 (de)
JP (1) JPH0676383B2 (de)
AT (1) ATE213231T1 (de)
CA (1) CA2100066C (de)
DE (1) DE69232417T2 (de)
WO (1) WO1992018125A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0594795B1 (de) * 1991-04-12 2002-02-13 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce Michellamine zur verwendung als antivirale wirkstoffe, zusammensetzung und behandlungsverfahren
WO1994024108A1 (en) * 1993-04-19 1994-10-27 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Michellamines useful as antiviral agents
US5571919A (en) * 1994-07-22 1996-11-05 The United States Of America As Represented By The Department Of Health And Human Services Dimeric naphthylisoquinoline alkaloids and synthesis methods thereof
US5578729A (en) * 1994-07-22 1996-11-26 The United States Of America As Represented By The Department Of Health And Human Services Dimeric arylisoquinoline alkaloid compounds
US6140339A (en) * 1994-02-14 2000-10-31 The United States Of America As Represented By The Department Of Health And Human Services Monomeric and dimeric arylisoquinoline alkaloids and derivatives thereof
US5552550A (en) * 1994-07-22 1996-09-03 The United States Of America, As Represented By The Department Of Health And Human Services Monomeric Naphthylisoquinoline alkaloids and synthesis methods thereof
US5639761A (en) 1994-02-14 1997-06-17 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Antimalarial naphthylisoquinoline alkaloids and pharmaceutical compositions and medical uses thereof
ES2197205T3 (es) * 1994-07-22 2004-01-01 The United States Of America, As Represented By The Secretary, Departm. Of Health And Human Services Alcaloides monomericos y dimericos de naftilisoquinoleina y procedimiento de sintesis de los mismos.
US5543523A (en) * 1994-11-15 1996-08-06 Regents Of The University Of Minnesota Method and intermediates for the synthesis of korupensamines
CN102532018A (zh) * 2011-12-20 2012-07-04 苏州宝泽堂医药科技有限公司 一种纯化米歇尔胺c的方法
CN110368407B (zh) * 2019-08-20 2021-07-13 大连民族大学 一种钩枝藤枝叶有效部位及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH541609A (de) * 1970-02-03 1973-09-15 Ciba Geigy Ag Verfahren zur Herstellung von Bi-isochinolinonen und deren Verwendung als Fluoreszenzfarbstoffe in Kunststoffen
EP0594795B1 (de) * 1991-04-12 2002-02-13 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce Michellamine zur verwendung als antivirale wirkstoffe, zusammensetzung und behandlungsverfahren

Also Published As

Publication number Publication date
ATE213231T1 (de) 2002-02-15
JPH06502186A (ja) 1994-03-10
CA2100066A1 (en) 1992-10-13
CA2100066C (en) 1996-08-13
US5654432A (en) 1997-08-05
WO1992018125A1 (en) 1992-10-29
EP0594795B1 (de) 2002-02-13
AU1880592A (en) 1992-11-17
DE69232417D1 (de) 2002-03-21
US5455251A (en) 1995-10-03
EP0594795A1 (de) 1994-05-04
JPH0676383B2 (ja) 1994-09-28
EP0594795A4 (de) 1993-12-07
AU657549B2 (en) 1995-03-16

Similar Documents

Publication Publication Date Title
GR3034279T3 (en) Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
NO922949L (no) Forbindelser og fremgangsmaater for inhibering av hiv- og beslektede virus
UA66744C2 (en) 5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections
ATE294577T1 (de) Verwendung von sulfamat derivaten zur behandlung von impulsiven störungen
MY138860A (en) Hiv protease inhibitors.
DE69019533T2 (de) Behandlung von hiv-infizierungen und nützliche verbindungen dafür.
DK0750618T3 (da) Oxazolidinonderivater og farmaceutiske præparater indeholdende dem
ATE298741T1 (de) Polyaromatische verbindungen zur behandlung von herpes-infektionen
ES2166823T3 (es) Nuevos derivados pirrolicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
DE60211539D1 (de) Imidazopyridinderivate zur verwendung bei der behandlung von herpes-vireninfektion
RU94020410A (ru) Способ лечения или профилактики рвоты у млекопитающих и человека с использованием некоторых хинуклидиновых, пиперидиновых, азанорборнановых, этилендиаминовых производных и родственных им соединений
DE69232417T2 (de) Michellamine zur verwendung als antivirale wirkstoffe, zusammensetzung und behandlungsverfahren
DE69518840D1 (en) N-(3-amino-2-hydroxybutyl)sulfonamid-derivate as hiv-protease-inhibitoren
DE69132575T2 (de) Sampangin-derivate zur verwendung als antimykotische und antimykobakterielle wirkstoffe
DK0604186T3 (da) HIV-proteaseinhibitorer, som er egnede til behandling af AIDS
ATE128871T1 (de) Verfahren zur behandlung von thrombocytopenie und dafür geeignete pharmazeutische zusammensetzungen.
UA37251C2 (uk) Лікарський засіб для лікування або профілактики вірусної інфекції гепатиту в і спосіб лікування вірусної інфекції гепатиту в
UA42693C2 (uk) Лікарський засіб для лікування інфекції лентивірусом, препарат для лікування людини, яка інфікована лентивірусом
AU3943397A (en) New antiviral lipopeptides, and a method of inactivating lipid-enveloped viruses using lipopeptides
NO179009C (no) Analogifremgangsmåte for fremstilling av salter av L-alfa-glyserofosforyl-D-myo-inositol
DE69117974T2 (de) Pharmazeutische zusammensetzungen zur behandlung von b-zell-entartungen
ATE113843T1 (de) Verwendung eines prolylendopeptidase-inhibitors zur behandlung von aids.
DE69429538D1 (de) Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 6 infektionen
TR199902508T2 (xx) HIV proteaz inhibit�rleri.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee